Topic: death

Despite deaths and trial halts, Leerink sees Juno positives

Juno took a major hit last year when a number of patients died in its experimental CAR-T test, which for months has remained under a cloud and another halt. But analysts at Leerink see reasons to be cheerful about its second next-gen blood cancer candidate.